Although Axsome is benefiting from Auvelity’s momentum and its broader commercial portfolio, the CNS space remains highly ...
A little-known treatment for heart failure, developed more than half a century ago and refined in the '70s, may have legs as ...
Money Talks News on MSN
1 in 4 Medicare patients with dementia get risky drugs. 6 questions families should ask
The memory-care unit wants to calm Mom down with a pill. Before you say yes, there's something they may have skipped.
New research links repeated gabapentin use with increased risk, prompting cautious monitoring for gabapentin and dementia ...
Biogen's Q3 earnings are due Oct 28. Explore FY2026 EPS guidance, Alzheimer’s revenue growth, and key risk/reward ...
Spread the loveImagine a world where an Alzheimer’s diagnosis doesn’t automatically mean an inevitable, rapid decline.
Arrowhead Pharmaceuticals, Inc. beats on ARO-MAPT with up to 85% CSF tau cut; CNS siRNA platform gains traction. Click for ...
NIH study involves members of well-known Colombian kindred at nearly certain genetic risk for early-onset Alzheimer’s diseasePhoenix, Oct. 15, 2026 (GLOBE NEWSWIRE) -- A new Alzheimer's disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results